E. Bel (Leiden, The Netherlands), M. Kraft (Denver, United States Of America)
The allergen specificity of the late asthmatic reaction
P. Hatzivlassiou, L. Little, J. Ward, V. Kehagia, S. Smith, I. Yang, P. H. Howarth (Southampton, United Kingdom)
|  |
Allergen challenge in asthma causes non-reversible small airways dysfunction that is missed by FEV1
E. L. J. van Rensen, N. Koning, C. E. Evertse, K. F. Rabe, P. J. Sterk (Leiden, The Netherlands)
| |
Vascular endothelial growth factor is upregulated in induced sputum of asthmatic patients after antigenic bronchoprovocation
R. H. Zwick, K. Patocka, M. Greger, O. Pachinger, H. Zwick (Innsbruck, Vienna, Austria)
| |
The Cys-LT1 receptor antagonist, pranlukast, attenuates allergen-induced increase in airway eosinophils and bone marrow derived eosinophil/basophil progenitors in subjects with atopic asthma
K. Parameswaran, R. Watson, T. Rerecich, J. Otis, T. Strinich, P. M. O'Byrne (Hamilton, Canada)
| |
Inhibition of allergen-iduced late asthmatic reaction by montelukast versus fluticasone propionate
M. Palmqvist, C. Bruce, M. Sjöstrand, P. Arvidsson, J. Lötvall (Gothenburg, Sweden)
| |
Dissimilarity between seasonal changes in airway responsiveness to adenosine-5'-monophosphate and methacholine in patients with grass pollen allergic rhinitis: relation to induced sputum
J. Beier, K. M. Beeh, O. Kornmann, R. Buhl (Mainz, Germany)
|  |
Inhaled AMP induces a systemic inflammatory response in mild asthmatics
B. Luijk, C. van Aalst, L. Koenderman, J. W. J. Lammers (Utrecht, The Netherlands)
| |
Adenosine 5' – triphosphate (ATP) and adenosine 5' – monophosphate (AMP) challenge testing in healthy non-smokers and patients with mild asthma
O. Kacmaz Basoglu, C. Brindicci, S. Essilfie-Quaye, P. J. Barnes, S. A. Kharitonov (Izmir, Turkey; London, United Kingdom)
| |